TP53 and cancer: Since p53R172H is known to bind to, and inhibit, other p53 family transcription factors as a mechanism of its gain-of-function properties in other cancer types, we examined the mRNA levels of a collection of genes known to be regulated by the related p63 and p73 proteins.